These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27254086)

  • 21. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to Maternal Depressive Symptoms in Fetal Life or Childhood and Offspring Brain Development: A Population-Based Imaging Study.
    Zou R; Tiemeier H; van der Ende J; Verhulst FC; Muetzel RL; White T; Hillegers M; El Marroun H
    Am J Psychiatry; 2019 Sep; 176(9):702-710. PubMed ID: 31055967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls.
    Seiger R; Gryglewski G; Klöbl M; Kautzky A; Godbersen GM; Rischka L; Vanicek T; Hienert M; Unterholzner J; Silberbauer LR; Michenthaler P; Handschuh P; Hahn A; Kasper S; Lanzenberger R
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):542-550. PubMed ID: 33667309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Prenatal Maternal Depression and Anxiety Symptoms With Infant White Matter Microstructure.
    Dean DC; Planalp EM; Wooten W; Kecskemeti SR; Adluru N; Schmidt CK; Frye C; Birn RM; Burghy CA; Schmidt NL; Styner MA; Short SJ; Kalin NH; Goldsmith HH; Alexander AL; Davidson RJ
    JAMA Pediatr; 2018 Oct; 172(10):973-981. PubMed ID: 30177999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prepartum and Postpartum Maternal Depressive Symptoms Are Related to Children's Brain Structure in Preschool.
    Lebel C; Walton M; Letourneau N; Giesbrecht GF; Kaplan BJ; Dewey D
    Biol Psychiatry; 2016 Dec; 80(11):859-868. PubMed ID: 26822800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
    Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
    Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
    Oberlander TF; Reebye P; Misri S; Papsdorf M; Kim J; Grunau RE
    Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.
    Skurtveit S; Selmer R; Roth C; Hernandez-Diaz S; Handal M
    BJOG; 2014 Dec; 121(13):1621-31. PubMed ID: 24726047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower inflammatory markers in women with antenatal depression brings the M1/M2 balance into focus from a new direction.
    Edvinsson Å; Bränn E; Hellgren C; Freyhult E; White R; Kamali-Moghaddam M; Olivier J; Bergquist J; Boström AE; Schiöth HB; Skalkidou A; Cunningham JL; Sundström-Poromaa I
    Psychoneuroendocrinology; 2017 Jun; 80():15-25. PubMed ID: 28292683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
    Handal M; Skurtveit S; Furu K; Hernandez-Diaz S; Skovlund E; Nystad W; Selmer R
    BJOG; 2016 Nov; 123(12):1908-1917. PubMed ID: 26374234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal antidepressant exposure and sex differences in neonatal corpus callosum microstructure.
    Campbell KSJ; Williams LJ; Bjornson BH; Weik E; Brain U; Grunau RE; Miller SP; Oberlander TF
    Dev Psychobiol; 2021 Sep; 63(6):e22125. PubMed ID: 33942888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.